Inability to fully suppress sterol synthesis rates with exogenous sterol in embryonic and extraembyronic fetal tissues

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 11, 2007, Pages 1372-1379

  Yao, Lihang ^a   Jenkins, Katie ^a   Horn, Paul S ^b   Lichtenberg, M Hayden ^a   Woollett, Laura A ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Cholesterol; Fetus; HMG CoA reductase; IUGR; Smith Lemli Opitz; SREBP 2

Indexed keywords

CHOLESTEROL; PROTEIN INSIG 1; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; STEROL REGULATORY ELEMENT BINDING PROTEIN CLEAVAGE ACTIVATING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYONAL TISSUE; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS LIVER; MALE; NONHUMAN; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; STEROL SYNTHESIS; SYRIAN HAMSTER; YOLK SAC;

ANIMALS; BASE SEQUENCE; CHOLESTEROL; CRICETINAE; CYCLOPHILINS; DNA PRIMERS; FEMALE; FETUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; LIVER; MALE; MEMBRANE PROTEINS; MESOCRICETUS; PLACENTA; PREGNANCY; RNA, MESSENGER; STEROLS; YOLK SAC;

MESOCRICETUS AURATUS;

EID: 36849089066     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2007.09.002     Document Type: Article

References (75)

1. Nwokoro N.A., Wassif C.A., and Porter F.D. Genetic disorders of cholesterol biosynthesis in mice and humans. Mol. Genet. Metab. 74 (2001) 105-119
2. Kelley R.I., and Herman G.E. Inborn errors of sterol biosynthesis. Annu. Rev. Genomics Hum. Genet. 2 (2001) 299-341
3. Porter F.D. Malformation syndromes due to inborn errors of cholesterol synthesis. J. Clin. Invest. 110 (2002) 715-724
4. Irons M., Elias E.R., Salen G., Tint G.S., and Batta A.K. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet 341 (1993) 1414
5. Shefer S., Salen G., Batta A.K., Honda A., Tint G.S., Irons M., Elias E.R., Chen T.C., and Holick M.F. Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. J. Clin. Invest. 96 (1995) 1779-1785
6. Porter F.D. RSH/Smith-Lemli-Opitz Syndrome: a multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis. Mol. Genet. Metab. 71 (2000) 163-174
7. Kelley R.I., and Hennikam R.C.M. The Smith-Lemli-Opitz syndrome. J. Med. Genet. 37 (2000) 321-335
8. Tint G.S., Salen G., Batta A.K., Shefer S., Irons M., Elias E.R., Abuelo D.N., Johnson V.P., Lambert M., and Lutz R. Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J. Pediatr. 127 (1995) 82-87
9. Woollett L.A. Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation. Am. J. Clin. Nutr. 82 (2005) 1155-1161
10. Lichtenberg M.H., Wilke C.S., McConihay J.A., Granholm N.A., and Woollett L.A. Yolk sac cholesteryl ester secretion rates can be manipulated in the Golden Syrian hamster: effect of yolk sac cholesterol concentrations. Biochim. Biophys. Acta 1735 (2005) 214-221
11. Schmid K.E., Davidson W.S., Myatt L., and Woollett L.A. The transport of cholesterol across a placental cell monolayer: implications for net transport of sterol from the maternal to fetal circulation. J. Lipid Res. 44 (2003) 1909-1918
12. Carr B.R., and Simpson E.R. Cholesterol synthesis in human fetal tissues. J. Clin. Endocrinol. Metab. 55 (1982) 447-452
13. Levin M.X., Pitt A.J.A., Schwartz A.L., Edwards P.A., and Gordon J.I. Developmental changes in the expression of genes involved in cholesterol biosynthesis and lipid transport in human and rat fetal and neonatal livers. Biochim. Biophys. Acta 1003 (1989) 293-300
14. Dietschy J.M., Turley S.D., and Spady D.K. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 34 (1993) 1637-1659
15. Yoshida S., and Wada Y. Transfer of maternal cholesterol to embryo and fetus in pregnant mice. J. Lipid Res. 46 (2005) 2168-2174
16. Tint G.S., Yu H., Shang Q., Xu G., and Patel S.B. The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols. J. Lipid Res. 47 (2006) 1535-1541
17. Nakanish M., Goldstein J.L., and Brown M.S. Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzymes. J. Biol. Chem. 263 (1988) 8929-8937
18. Brown M.S., and Goldstein J. Regulation of the mevalonate pathway. Nature 343 (1990) 425-430
19. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 (2002) 1125-1131
20. Horton J.D., and Shimomura I. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr. Opin. Lipidol. 10 (1999) 143-150
21. Osborne T.F. Sterol regulatory element binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 275 (2000) 32379-32382
22. Yabe D., Brown M.S., and Goldstein J.L. Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12753-12758
23. Yang T., Espenshade P.J., Wright M.E., Yabe D., Gong Y., Aebersold R., Goldstein J.L., and Brown M.S. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110 (2002) 489-500
24. Radhakrishnan A., Sun L.-P., Kwon H.J., Brown M.S., and Goldstein J.L. Direct binding of cholesterol to the pruified membrane region of SCAP: mechanism for a sterol-sensing domain. Mol. Cell 15 (2004) 259-268
25. Engelking L.J., Kuriyama H., Hammer R.E., Horton J.D., Brown M.S., Goldstein J.L., and Liang G. Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J. Clin. Invest. 113 (2004) 1168-1175
26. Yang T., Goldstein J.L., and Brown M.S. Overexpression of membrane domain of SCAP prevents sterols from inhibiting SCAP/SREBP exit from endoplasmic reticulum. J. Biol. Chem. 275 (2000) 29881-29886
27. Shimano H., Horton J.D., Shimomura I., Hammer R.E., Brown M.S., and Goldstein J.L. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Invest. 99 (1997) 846-854
28. Spady D.K., and Dietschy J.M. Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. J. Clin. Invest. 81 (1988) 300-309
29. McConihay J.A., Horn P.S., and Woollett L.A. The effect of maternal hypercholesterolemia on fetal sterol metabolism in the Golden Syrian hamster. J. Lipid Res. 42 (2001) 1111-1119
30. Yao L., Dawson P.A., and Woollett L.A. Increases in biliary cholesterol-to-bile acid ratio in pregnant hamsters fed low and high levels of cholesterol. Am. J. Physiol. 284 (2003) G263-G268
31. Woollett L.A. Origin of cholesterol in the fetal Golden Syrian hamster: contribution of de novo sterol synthesis and maternal-derived lipoprotein cholesterol. J. Lipid Res. 37 (1996) 1246-1257
32. Dietschy J.M., and Spady D.K. Measurement of rates of cholesterol synthesis using tritiated water. J. Lipid Res. 25 (1984) 1469-1476
33. Belknap W.M., and Dietschy J.M. Sterol synthesis and low density lipoprotein clearance in vivo in the pregnant rat, placenta, and fetus. Sources for tissue cholesterol during fetal development. J. Clin. Invest. 82 (1988) 2077-2085
34. Turley S.D., Herndon M.W., and Dietschy J.M. Reevaluation and application of the dual-isotope plasma ratio method for the measurement of intestinal cholesterol absorption in the hamster. J. Lipid Res. 35 (1994) 328-339
35. Botolin D., and Jump D.B. Selective proteolytic processing of rat hepatic sterol regulatory element binding protein-1 (SREBP-1) and SREBP-2 during postnatal development. J. Biol. Chem. 278 (2003) 6959-6962
36. Jelinek D.F., Andersson S., Slaughter C.A., and Russell D.W. Cloning and regulation of cholesterol 7α-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J. Biol. Chem. 265 (1990) 8190-8197
37. Jegathesan J., Liebenthal J.A., Arnett M.G., Clancy R.L., and Pierce J.D. Apoptosis: understanding the new molecular pathway. Med. Nurs. 13 (2004) 371-376
38. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
39. Shimomura I., Bashmakov Y., Shimano H., Horton J.D., Goldstein J.L., and Brown M.S. Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12354-12359
40. Yabe D., Xia Z.-P., Adams C.M., and Rawson R.B. Three mutations in sterol-sensing domain of SCAP block interaction with Insig and render SREBP cleavage insensitive to sterols. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16672-16677
41. Sever N., Song B.-L., Yabe D., Goldstein J.L., Brown M.S., and DeBose-Boyd R.A. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J. Biol. Chem. 278 (2003) 52479-52490
42. Field F.J., Born E., and Mathur S.N. Fatty acid flux suppresses fatty acid synthesis in hamster intestine independently of sterol regulatory element-binding protein-1 expression. J. Lipid Res. 44 (2003) 1199-1208
43. Bobard A., Hainault I., Ferré P., Foufelle F., and Bossard P. Differential regulation of sterol regulatory element-binding protein 1c transcriptional activity by insulin and liver X receptor during liver development. J. Biol. Chem. 280 (2005) 199-206
44. Turley S.D., Spady D.K., and Dietschy J.M. Identification of a metabolic difference accounting for the hyper- and hyporesponder phenotypes of cynomologus monkey. J. Lipid Res. 38 (1997) 1598-1611
45. Bortoff K.D., Zhu C.C., Hrywna Y., and Messina J.L. Insulin induction of pip92, CL-6 and novel mRNAs in rat hepatoma cells. Endocrine 7 (1997) 199-207
46. Sugden M.C., and Holness M.J. Potential role of peroxisome proliferator-activated receptor-alpha in the modulation of glucose-stimulated insulin secretion. Diabetes 53 (2004) S71-S81
47. Herrera E., Munoz C., Lopez-Luna P., and Ramos P. Carbohydrate-lipid interactions during gestation and their control by insulin. Braz. J. Med. Biol. Res. 27 (1994) 2499-2519
48. Lee J.N., Song B., DeBose-Boyd R.A., and Ye J. Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J. Biol. Chem. 281 (2006) 39308-39315
49. Schmid K.E., and Woollett L.A. Differential effects of polyunsaturated fatty acids on sterol synthesis rates in adult and fetal tissues of the hamster: consequence of altered sterol balance. Am. J. Physiol. 285 (2003) G796-G803
50. Hirano Y., Yoshida M., Shimizu M., and Sato R. Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway. J. Biol. Chem. 276 (2001) 36431-36437
51. Sundquist A., and Ericsson J. Transcription-dependent degradation controls the stability of the SREBP family of transcription factors. Proc. Natl. Acad. Sci. 100 (2003) 13833-13838
52. Punga T., Bengoechea-Alonso M.T., and Ericsson J. Phosphorylation and ubiquitination of the transcription factor sterol regulatory element-binding protein-1 in response to DNA binding. J. Biol. Chem. 381 (2006) 25278-25286
53. An J.Y., Seo J.W., Tasaki T., Lee M.J., Varshavsky A., and Kwon Y.T. Impaired neurogenesis and cardiovascular development in mice lacking the E3 ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway. Proc. Natl. Acad. Sci. 103 (2006) 6212-6217
54. Bowerman B., and Kurtz T. Degrade to create: developmental requirements for ubiquitin-mediated proteolysis during early C. elegans embryogenesis. Development 133 (2006) 773-784
55. Riddle T.M., Kuhel D.G., Woollett L.A., Ficktenbaum C.J., and Hui D.Y. HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus. J. Biol. Chem. 276 (2001) 37514-37519
56. Song B.-L., Sever N., and DeBose-Boyd R.A. Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated uiquitination to degradation of HMG CoA reductase. Mol. Cell 19 (2005) 829-840
57. Sever N., Song B.-L., Yabe D., Goldstein J.L., Brown M.S., and DeBose-Boyd R.A. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J. Biol. Chem. 278 (2003) 52479-52490
58. Song B.-L., Javitt N.B., and DeBose-Boyd R.A. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab. 1 (2005) 179-189
59. Brown M.S., and Goldstein J.L. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J. Lipid Res. 21 (1980) 505-517
60. Elias E.R., Irons M.B., Hurley A.D., Tint G.X., and Salen G. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS). Am. J. Med. Genet. 68 (1997) 305-310
61. Irons M., Elias E.R., Abuelo D., Bull M.J., Greene C.L., Johnson V.P., Keppen L., Schanen C., Tint G.S., and Salen G. Treatment of Smith-Lemli-Opitz syndrome: results of a multi-center trial. Am. J. Med. Genet. 68 (1997) 311-314
62. Nwokoro N.A., and Mulvihill J.J. Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO-RSH) syndrome. Am. J. Med. Genet. 68 (1997) 315-321
63. Molteni R.A. Placental growth and fetal/placental weight (F/P) ratios throughout gestation - their relationship to patterns of fetal growth. Semin. Perinatol. 8 (1984) 94-100
64. Heinonen S., Taipale P., and Saarikoski S. Weights of placentae from small-for-gestational age infants revisited. Placenta 22 (2001) 399-404
65. Pardi G., Marconi A.M., and Cetin E. Placental-fetal interrelationship in IUGR fetuses - a review. Placenta 23 (2002) S136-S141
66. Porter J.A., Young K.E., and Beachy P.A. Cholesterol modification of hedgehog signaling proteins in animal development. Science 274 (1996) 255-259
67. Cooper M.K., Porter J.A., Young K.E., and Beachy P.A. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280 (1998) 1603-1607
68. Chiang C., Litingtung Y., Lee E., Young K.E., Corden J.L., Wesphal H., and Beachy P.A. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 383 (1996) 407-413
69. Cooper M.K., Wassif C.A., Krabowiak P.A., Taipale J., Gong R., Kelley R.I., Porter F.D., and Beachy P.A. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat. Genet. 33 (2003) 508-513
70. Marti E., and Bovolenta P. Sonic hedgehog in CNS development: one signal, multiple outputs. Trends Neurosci. 25 (2002) 89-96
71. Roessler E., Belloni E., Gaudenz K., Jay P., Berta P., Scherer S.W., Tsui L.C., and Muenke M. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat. Genet. 14 (1996) 357-360
72. Kelley R.L., Roessler E., Hennekam R.C., Feldman G.L., Kosaki K., Jones M.C., Palumbos J.C., and Muenke M. Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog?. Am. J. Med. Genet. 66 (1996) 478-484
73. Tulenko T.M., Boeze-Battaglia K., Mason R.P., Tint G.S., Steiner R.D., Connor W.E., and Labelle E.F. A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome. J. Lipid Res. 47 (2006) 134-143
74. Kovarova M., Wassif C.A., Odom S., Liao K., Porter F.D., and Rivera J. Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness. J. Exp. Med. 203 (2006) 1161-1171
75. Keller R.K., Arnold T.P., and Fliesler S.J. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome. J. Lipid Res. 45 (2004) 347-355